Právní předpis byl sestaven k datu 13.05.2009.
Zobrazené znění právního předpisu je účinné od 13.05.2009 do 30.12.2011.
xxxxx xxxx- xxxxxxxx skupiny |
terapeutická skupina |
číslo xxxxxxxxxx skupiny |
referenční skupina*) |
léčivé xxxxx v xxxxxxxxxx xxxxxxx xxxxxxxxxxx |
1 |
Xxxxxx k xxxxxxx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxx x xxxxxxxx xxxxxxx jícnu |
1/2 |
léčiva x xxxxxxx gastroduodenální xxxxxxx xxxxxxx a xxxxxxxx xxxxxxx jícnu, xxxxxxxxxxx X2 receptorů, parent. |
A02BA01 xxxxxxxxx, X02XX02 xxxxxxxxx, X02XX03 famotidin |
1/3 |
léčiva x xxxxxxx gastroduodenální xxxxxxx choroby x xxxxxxxx xxxxxxx xxxxx, xxxxxxxxxx xxxxxxxxx pumpy, x.x. |
X02XX01 xxxxxxxxx, X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxxxx, X02XX05 xxxxxxxxxxx |
||
1/4 |
xxxxxx x xxxxxxx xxxxxxxxxxxxxxxx xxxxxxx xxxxxxx x xxxxxxxx xxxxxxx xxxxx, inhibitory xxxxxxxxx xxxxx, xxxxxx. |
X02XX01 xxxxxxxxx, X02XX02 xxxxxxxxxxx, X02XX05 xxxxxxxxxxx |
||
2 |
Xxxxxxxxxxxx |
2/1 |
xxxxxxxxxxxx, x.x. |
X03XX04 xxxxxxxxx, X03XX06 xxxxxxxxx xxxxxx, X03XX02 drotaverin, A03BB01 butylskopolamin |
2/2 |
spasmolytika, xxxxxx. |
X03XX01 papaverin, A03AD02 xxxxxxxxxx |
||
3 |
Xxxxxxxxxxx |
3/1 |
xxxxxxxxxxx, x.x. |
X03XX01 xxxxxxxxxxxxx, X03XX03 xxxxxxxxxx, X03XX xxxxxxx |
4 |
Xxxxxxxxxxx |
4/1 |
xxxxxxxxxxx, setrony, p.o. |
A04AA01 xxxxxxxxxxx, X04XX02 xxxxxxxxxxx |
4/2 |
xxxxxxxxxxx, setrony, xxxxxx. a xxxx. xxxxxxxx |
X04XX01 ondansetron, A04AA02 xxxxxxxxxxx, X04XX05 xxxxxxxxxxxx |
||
4/3 |
xxxxxxxxxxx, xxxxxxx, x.x |
X06XX03 xxxxxxxxxxxxxxx, X04XX embramin |
||
5 |
Léčiva k xxxxxxx xxxxxxxxxxx střevních xxxxxxxxxx |
5/1 |
xxxxxx x terapii xxxxxxxxxxx xxxxxxxxx onemocnění, xxxxxxxx arninosalicylová x xx xxxxx xxxxxxx, x.x. |
X07XX01 sulfasalazin, A07EC02 mesalazin |
6 |
Protiprůjmové xxxxxxxxxxxxxx |
6/1 |
xxxxxxxxxxxxx mikroorganismy, x.x. |
X07XX xxxxxxxxxxxxx xxxxxxxxxxxxxx - Xxxxxxxxxxx xxxx, X07XX01 xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxx, X07XX02 Xxxxxxxxxxxxx xxxxxxxx xxxxxxx |
7 |
Xxxxxxxxxxxxx xxxxxxxxx |
7/1 |
xxxxxxxxxxxxx xxxxxxxxx, xxxxxxxxxxxxx xxxxxx formy, x.x. |
X09XX02 xxxxxxxxxxxxx přípravky - xxxxxxxxxxxxx xxxxxx xxxxx xxx 20 000 U x jedné xxxxxxx |
8 |
Xxxxxx x xxxxxxx xxxxxxx - insuliny |
8/1 |
léčiva x xxxxxxx diabetu, xxxxxxx xxxxxx - xxxxxxxx, xxxxx. |
X10XX01 insulin xxxxxx xxxxxx působící, A10AC01 xxxxxxx xxxxxx středně dlouze xxxxxxxx |
8/2 |
xxxxxx x xxxxxxx xxxxxxx, insulin xxxxxx - xxxxxxxxx, xxxxxxx xxxxxxxx - xxxxxxxx x xxxxxxxxx, parent. |
A10AB01 xxxxxxx xxxxxx, X10XX04 insulin xxxxxx, X10XX05 xxxxxxx xxxxxx, X10XX06 xxxxxxx xxxxxxxx, X10XX01 xxxxxxx xxxxxx, X10XX01 xxxxxxx xxxxxx, X10XX04 xxxxxxx lispro, A10AD05 insulin xxxxxx, |
||
8/3 |
xxxxxx x xxxxxxx xxxxxxx, xxxxxxxx a xxxxxxx xxxxxx xxxxxxxx, xxxxxx. |
X10XX04 xxxxxxx xxxxxxx, X10XX05 xxxxxxx xxxxxxx |
||
9 |
Xxxxxx k xxxxxxx xxxxxxx |
9/1 |
xxxxxx x xxxxxxx xxxxxxx, xxxxxxxx xxxxxxxxxxxx - X. x II. generace, x.x. (xxxxx glipizidu, xxxxxxxxxx x glimepiridu) |
A10BB01 xxxxxxxxxxxx, X10XX03 xxxxxxxxxx, |
9/2 |
xxxxxx x xxxxxxx xxxxxxx, deriváty xxxxxxxxxxxx - X. xxxxxxxx, x.x. |
X10XX07 xxxxxxxx, X10XX09 xxxxxxxxx, X10XX12 xxxxxxxxxx |
||
9/3 |
xxxxxx x xxxxxxx xxxxxxx, glitazony, x.x. |
X10XX02 rosiglitazon, A10BG03 xxxxxxxxxxx |
||
9/4 |
xxxxxx x xxxxxxx diabetu, xxxxxxx, p.o. |
A10BX02 repaglinid, A10BX03 xxxxxxxxxx |
||
9/5 |
xxxxxx x xxxxxxx xxxxxxx, léčiva ovlivňující xxxxxxxxxxx xxxxxx |
X10XX01 xxxxxxxxxxx, X10XX02 xxxxxxxxxxxx, X10XX04 exenatid, A10BX07 xxxxxxxxxx |
||
10 |
Xxxxxx x terapii xxxxxxxx xxxxxxxx |
10/1 |
xxxxxx k terapii xxxxxxxx xxxxxxxx, xxxx xxxxxxx, p.o. |
A12AA04 xxxxxxxxx xxxxxxxx, X12XX07 chlorid xxxxxxxx |
10/2 |
xxxxxx x terapii xxxxxxxx xxxxxxxx, xxxx xxxxxxx, x.x. |
X12XX06 xxxxxxx xxxxxxxxx, X12XX09 xxxxxx xxxxxxxxx |
||
11 |
Xxxxxx x xxxxxxxxxx substituční xxxxxxx xxxxxxxxx poruch xxxxxxxxxx xxxxxxxxxxx |
11/1 |
xxxxxx x xxxxxxxxxx xxxxxxxxxxx terapii dědičných xxxxxx xxxxxxxxxx metabolismu, xxxxxx. |
X16XX03 xxxxxxxxxx alfa, A16AB04 xxxxxxxxxx beta |
12 |
Léčiva k xxxxxxx nebo x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx |
12/1 |
xxxxxx x xxxxxxx xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, xxxxxxxxxxxxxxxx xxxxxxxx, xxxxx xxxx xxxxxx xxxxxxxxx x xxxxxxxxx XXX, parent. |
B01AB04 dalteparin, B01AB05 xxxxxxxxxx, X01XX06 xxxxxxxxxx, X01XX08 xxxxxxxxx, X01XX12 xxxxxxxxx |
12/2 |
xxxxxx x terapii xxxx k xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, nízkomolekulární xxxxxxxx, xxxxx xxxx xxxxxx především k xxxxxxx XXX, parent. |
B01AB04 xxxxxxxxxx, X01XX05 xxxxxxxxxx, X01XX06 xxxxxxxxxx, X01XX08 xxxxxxxxx, X01XX12 xxxxxxxxx |
||
12/3 |
xxxxxx k xxxxxxx nebo k xxxxxxxxx xxxxxxxxxxxxxxxxx onemocnění, xxxxx inhibitory xxxxxxx Xx a trombinu, xxxxxx. |
X01XX01 xxxxxxxxx, X01XX02 lepirudin, B01AE06 xxxxxxxxxxx |
||
13 |
Xxxxxx k xxxxxxx xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx |
13/1 |
xxxxxx x xxxxxxx xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, xxxxxxxxxxx vazby XXX xx receptor, x.x. |
X01XX04 xxxxxxxxxxx, X01XX05 tiklopidin, |
13/2 |
léčiva x xxxxxxx xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxxxx xxxxxxx Xx x xxxxxxxx, x.x. |
X01XX07 xxxxxxxxxx, X01X rivaroxaban, B01A xxxxxxxx |
||
14 |
Xxxxxxxxxx léčiva x xxxxxxx plicní arteriální xxxxxxxxxx (XXX) |
14/1 |
xxxxxxxxxx xxxxxx x xxxxxxx xxxxxx xxxxxxxxxx hypertenze (XXX), xxxxxx. x xxxxx. xxxxxxxx |
X01XX09 xxxxxxxxxxxx, X01XX11 xxxxxxxx, X01XX21 xxxxxxxxxxxx |
14/2 |
xxxxxxxxxx léčiva x xxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx (XXX), p.o. |
C02KX01 xxxxxxxx, X02XX02 ambrisentan, C02KX03 sitaxentan, C02K xxxxxxxxxx |
||
15 |
Xxxxxxxxxxxxx, xxxxxx. |
15/1 |
xxxxxxxxxxxxx, enzymy, xxxxxx. |
X01XX02 altepláza, B01AD04 xxxxxxxxx, X01XX11 xxxxxxxxxxxx |
16 |
Xxxxxxxxxxxxxxxxx - xxxxxxxxxxxxx |
16/1 |
xxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, x.x. |
X02XX02 xxxxxxxx xxxxxxxxxxx, X02XX03 xxxxxxxx xxxxxxxxxxxxxxxxxxx |
16/2 |
xxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxx. |
X02XX02 xxxxxxxx xxxxxxxxxxx, X02XX03 xxxxxxxx aminomethylbenzoová |
||
17 |
Léčiva x xxxxxxx xxxxxx - soli železa |
17/1 |
léčiva x xxxxxxx xxxxxx, xxxxxxxxx xxxx xxxxxxxxx xxxxxx, p.o. |
B03AA02 xxxxxxx xxxxxxxxx, X03XX07 síran xxxxxxxxx, X03XX02 xxxxxxx xxxxxx x xxxxxxxxxxx |
17/2 |
xxxxxx k xxxxxxx xxxxxx, xxxxxxxxx železo, xxxxxx. |
X03XX02 xxxxxxx xxxxxx x xxxxxxxxxxx, X03XX07 xxxxxxxx xxxxx-xxxxxxxx |
||
18 |
Xxxxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xx receptor xxxxxxxxxxxxxx |
18/1 |
xxxxxxx xxxxxxxxxxx erytropoézu, xxxxxx. |
X03XX01 erythropoetin (xxxxxxx xxxx), X03XX02 darbepoetin xxxx, X03XX03 xxxxxxxxxx (Xxxxxx-xxxxxxxxxxxxxxxx- xxxxxxx xxxx), xxxxxxx xxxx, xxxxxxx delta, xxxxxxx xxxx |
20 |
Xxxxxxxx XX x xxxxxxx angíny xxxxxxxx |
20/1 |
xxxxxxxx XX k xxxxxxx xxxxxx xxxxxxxx - xxxxxxx xxxxxxxx xxxxxxxx, subling. |
C01DA02 xxxxxxxx trinitrát, C01DA08 xxxxxxxxx xxxxxxxx |
20/2 |
xxxxxxxx XX x xxxxxxx anginy pectoris - xxxxxxx xxxxxxxxxx, x.x. |
X01XX02 glycerol xxxxxxxxx, X01XX08 xxxxxxxxx xxxxxxxx, X01XX14 xxxxxxxxx xxxxxxxxxx, X01XX12 molsidomin |
||
20/3 |
donátory XX x xxxxxxx xxxxxx xxxxxxxx, xxxxxx. |
X01XX02 xxxxxxxx xxxxxxxxx, X01XX08 isosorbid dinitrát |
||
21 |
Antihypertenziva |
21/1 |
antiadrenergní xxxxx xxxxxxxx centrálně x xxxxxxxxx, x.x. (xxxxx prazosinu) |
C02AB01 methyldopa, C02AC05 xxxxxxxxx, X02XX06 xxxxxxxxxx, X02XX06 xxxxxxxx |
22 |
Xxxxxxxxx |
22/1 |
xxxxxxxxx, x.x. |
X03XX03 xxxxxxxxxxxxxxxxxx, X03XX04 xxxxxxxxxxxx, X03XX11 xxxxxxxxx, X03XX xxxxxxxxx |
23 |
Xxxxxxxxxxxxxxxx - xxxx-xxxxxxxxx |
23/1 |
xxxxxxxxxxxxxxxx, betablokátory xxxxxxxxxxxxxxxx xxxxxxxxxxxxx x xxxxxxxxxx xxxxxxxx, x.x. |
X07XX17 xxxxxxxxxx, X07XX02 xxxxxxxxxx (xxxxxxxxxxxxx xxxxxx xxxxx), X07XX03 xxxxxxxx, |
23/2 |
xxxxxxxxxxxxxxxx, xxxxxxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxx a xxxxxxxxxx xxxxxxxx, p.o. |
C07AB02 xxxxxxxxxx (xxxxxxxxxxx lékové xxxxx), X07XX04 xxxxxxxx, X07XX05 xxxxxxxxx, X07XX07 xxxxxxxxxx, X07XX08 xxxxxxxxxx, X07XX12 nebivolol, C07AG02 xxxxxxxxxx |
||
24 |
Xxxxxxxxxxxxxxxx - blokátory xxxxxxxxxx xxxxxx |
24/1 |
xxxxxxxxxxxxxxxx, xxxxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxxxxxxxxxxx xxxx xxxxxxxxxx působící, x.x. |
X08XX01 amlodipin, C08CA02 xxxxxxxxx (xxxxxxxxxxx xxxxxx formy), C08CA03 xxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X08XX08 xxxxxxxxxxx, X08XX09 xxxxxxxxx, X08XX10 xxxxxxxxxx, X08XX12 xxxxxxxxxx, X08XX13 xxxxxxxxxxxx |
24/2 |
xxxxxxxxxxxxxxxx, xxxxxxxxx kalciových xxxxxx xxxxxxxxxxxxxxxxxxx xxxx xxxxxxxxxx x xxxxxxxxxxx xxxxxxxx, x.x. |
X08XX02 xxxxxxxxx (xxxxxxxxxxxxx xxxxxx xxxxx), X08XX03 isradipin (xxxxxxxxxxxxx xxxxxx formy), C08CA05 xxxxxxxxx (xxxxxxx lékové xxxxx) |
||
24/3 |
xxxxxxxxxxxxxxxx, xxxxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxxxxxxxxxxx x xxxxxxxxxxxxxxxxxxx typu, p.o. |
C08DA01 xxxxxxxxx, X08XX01 xxxxxxxxx |
||
25 |
Xxxxxxxxxxxxxxxx - xxxxxx xxxxxxxx xx xxxxxx xxxxx- xxxxxxxxxxx-xxxxxxxxxx |
25/1 |
xxxxxxxxxxxxxxxx, xxxxxxxxxx XXX krátkodobě x xxxxxxxxxxx působící, x.x |
X09XX01 xxxxxxxxx, X09XX02 xxxxxxxxx, X09XX06 xxxxxxxxx |
25/2 |
xxxxxxxxxxxxxxxx, xxxxxxxxxx XXX xxxxxxxxxx xxxxxxxx, x.x. |
X09XX03 xxxxxxxxxx, X09XX04 perindopril, C09AA05 xxxxxxxx, X09XX08 xxxxxxxxxx, X09XX09 xxxxxxxxxx, X09XX10 xxxxxxx xxxxx, X09XX11 xxxxxxxxx, X09XX13 moexipril, C09AA16 xxxxxxxxx |
||
25/3 |
xxxxxxxxxxxxxxxx, xxxxxxxxxxx xxxxxxxxxxxx XX xxxxxxx, p.o. |
C09CA01 xxxxxxxx, X09XX02 eprosartan, C09CA03 valsartan, C09CA04 xxxxxxxxxx, X09XX06 xxxxxxxxxxx, X09XX07 xxxxxxxxxxx, X09XX08 xxxxxxxxxx |
||
25/4 |
xxxxxxxxxxxxxxxx, xxxxxxxxxxx xxxxxxxxxxx, x.x. |
X03XX01 xxxxxxxxxxxxx, X03XX04 eplerenon |
||
26 |
Periferní xxxxxxxxxxxxxx |
26/1 |
xxxxxxxxx xxxxxxxxxxxxxx, x.x. (xxxxx xxxxxxxxxxxxxxx námelových xxxxxxxxx x kombinací xxxxxxxxxxxxxxxxxxx) |
X04XX02 xxxxxxxx xxxxxxxxx, X04XX03 xxxxxxxxxxxx, X04XX02 xxxxxxxxxx, X04XX21 naftidrofuryl, C04DA04 xxxxxxxxx xxxxxxxxx |
26/2 |
xxxxxxxxx xxxxxxxxxxxxxx, xxxxxx. |
X04XX02 tolazolin, C04AD03 pentoxifylin, C04AD xxxxxxxx |
||
27 |
Xxxxxxxxxxx |
27/1 |
xxxxxxxxxxx, p.o. |
C05BX01 dobesilat xxxxxxxx, X05XX04 troxerutin, C05CA53 xxxxxxx xxxxxxxxx X05XX01 xxxxxxxxxx, X05XX xxxxx |
28 |
Xxxxxxxxxxxxxx |
28/1 |
xxxxxxxxxxxxxx, stativy, x.x. |
X10XX01 xxxxxxxxxxx, X10XX02 xxxxxxxxxx, X10XX03 xxxxxxxxxxx, X10XX04 xxxxxxxxxxx, X10XX05 xxxxxxxxxxxx, X10XX07 xxxxxxxxxxxx |
28/2 |
xxxxxxxxxxxxxx, xxxxxxx, p.o. |
C10AB02 xxxxxxxxxx, X10XX05 xxxxxxxxxx, X10XX08 ciprofibrát |
||
29 |
Antimykotika xxxxxxxxx x xxxxxxxxxxxx |
29/1 |
xxxxxxxxxxxx používaná x xxxxxxxxxxxx x xxxxxxx xxxxxxx, (xxxxx xxxxxxxxx xxxxxxxxxxxxxxxxxxxxx x xxxxxxxxxxxxx xxxxxxxxxxx) |
X01XX01 xxxxxxxx, X01XX02 xxxxxxxx, X01XX01 klotrimazol, D01AC03 xxxxxxxx, X01XX08 xxxxxxxxxxx, X0x XX10 xxxxxxxxx, X01XX11 xxxxxxxxxx, X01XX16 xxxxxxxxxxx, X01XX14 ciklopirox, D01AE15 xxxxxxxxxx, X01XX22 xxxxxxxx |
29/2 |
xxxxxxxxxxxx xxxxxxxxx x xxxxxxxxxxxx x xxxxxxx xxxxxxx, xxxxxxx |
X01XX04 xxxxxxxx undecylenová, D01AE jiná xxxxxxxxxxxx x zevnímu xxxxxxx |
||
30 |
Xxxxxxxxxxxxxx používaná x xxxxxxxxxxxx |
30/1 |
xxxxxxxxxxxxxx xxxxxxxxx v xxxxxxxxxxxx x xxxxxxx xxxxxxx, xxxxx |
X05XX xxxxx, X05XX xxxxx (xxxxxxxxx dehet) |
30/2 |
antipsoriatika xxxxxxxxx x xxxxxxxxxxxx x lokální terapii, xxxx xxxxxx xxx xxxxx |
X05XX02 calcipotriol, D05AX03 calcitriol, D05AX04 xxxxxxxxxx, X05XX05 tazaroten |
||
31 |
Antibiotika xxxxxxxxx x lokální terapii |
31/1 |
antibiotika xxxxxxxxx x xxxxxxx xxxxxxx |
X06XX01 xxxxxxxx xxxxxxxx, X06XX09 xxxxxxxxx |
32 |
Xxxxxxxxxxxxxxx xxxxxxxxx k xxxxxxx xxxxxxx - xxxxx a xxxxxxx xxxxx |
32/1 |
xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxx, slabé x xxxxxxx silné 1. x 2. xxxxxxxx |
X07XX19 xxxxxxxxxxxx xxxxxx (0,01%), X07XX04 fluocinolon xxxxxxxx (0,01%), X07XX02 xxxxxxxxxxxxx xxxxxx (1,0%), X07XX03 xxxxxxxxxxx (0,4%), X07XX09 xxxxxxxxxxxx acetonid (0,1%) |
32/2 |
xxxxxxxxxxxxxxx xxxxxxxxx k xxxxxxx xxxxxxx, slabé a xxxxxxx xxxxx 3. x 4. xxxxxxxx |
X07XX10 xxxxxxxxxxxxx (0,05%), D07AB08 desonid, D07AB02 xxxxxxxxxxxxxx xxxxxxx (0,1%) |
||
33 |
Xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxxx x xxxxx xxxxx |
33/1 |
xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxx, xxxxx a xxxxx xxxxx 1. a 2. xxxxxxxx |
X07XX04 xxxxxxxxxxx xxxxxxxx (0,05%- 0,2%), X07XX03 xxxxxxxxxxxxxx (0,25%) |
33/2 |
xxxxxxxxxxxxxxx xxxxxxxxx k xxxxxxx terapii, xxxxx x xxxxx xxxxx 3. a 4. xxxxxxxx |
X07XX01 xxxxxxxxxxxx xxxxxxx (0,1%), X07XX01 xxxxxxxxxxxx xxxxxxxxxxx (0,05%), X07XX17 fiutikason propionát (0,05%), X07XX12 Xxxxxxxxxxx propionát (0,05%), X07XX02 Xxxxxxxxxx (0,1%), D07AD01 xxxxxxxxxx propionát (0,05%), X07XX14 xxxxxxxxxxxxxxxxx xxxxxxxx (0,1%), X07XX13 xxxxxxxxx xxxxxx (0,1%), X07XX18 xxxxxxxxxxxx |
||
34 |
Xxxxxxxxxxx x dezinficiencia |
34/1 |
antiseptika x xxxxxxxxxxxxxx - xxxxxxxxxx xxxxxxxxx xxxxx |
X08XX xxxxxxxxxx xxxxxxxxxx xxxxxxxxx xxxxx |
35 |
Xxxxxx používaná k xxxxxxx terapii xxxx xxxxxxxx |
35/1 |
xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxx xxxxxxxx, xxxxxxxxx |
X10XX01 tretinoin, D10AD03 xxxxxxxx, X10XX04 xxxxxxxxxxxx |
35/2 |
xxxxxx používaná x xxxxxxx xxxxxxx xxxx xxxxxxxx, xxxxxxx xxxxxx |
X10XX01 xxxxxxx peroxid, D10AX03 xxxxxxxx xxxxxxxx |
||
35/3 |
xxxxxx xxxxxxxxx x lokální xxxxxxx xxxxxxxxxxxx, xxxxxxxxxxxx látky |
D10AF01 xxxxxxxxxxx, X10XX02 xxxxxxxxxxxx |
||
36 |
Xxxxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxx dennatitidy |
36/1 |
imimomodidancia xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxx dennatitidy |
D11AX14 takrolimus, D11AX15 xxxxxxxxxxxxx |
37 |
Xxxxxxxxxxxxx xxxxxxxxxxxx |
37/1 |
xxxxxxxxxxxxx xxxxxxxxxxxx, xxx. xxxx xxx. xxxxxxxx |
X01XX02 klotrimazol, G01AF05 xxxxxxxx, X01XX12 xxxxxxxxxxxx |
38 |
Xxxxxxxxxxxxx xxxxxxxxxxx |
38/1 |
xxxxxxxxxxxxx xxxxxxxxxxx, xxx. nebo vag. xxxxxxxx, (xxxxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxx) |
X0XXX03 polylcresulen, G01AX11 xxxxxxxxx jód, G01AX xxxxxxxxxxxx xxxxx |
39 |
Xxxxxxxxxxxxx antibiotika xxxxxxxxx x xxxxxxx xxxxxxx |
39/1 |
xxxxxxxxxxxxx xxxxxxxxxxx, xxx. nebo xxx. xxxxxxxx |
X01XX02 xxxxxxxxx, X01XXX0 xxxxxxxxxxx, X01XX12 xxxxxxxxxx |
40 |
Xxxxxxxxxxxxxx |
40/1 |
xxxxxxxxxxxxxx, xxxxxx. |
X02XX01 xxxxxxxxx, X02XX04 xxxxxxxxxx |
41 |
Xxxxxxxxxx xxxxxxxxxx |
41/1 |
xxxxxxxxxx xxxxxxxxxx, xxxxxxxxxxxx xxxxxxxx X. generace, x.x. |
X02XX01 xxxxxxxxxxxx, X02XX0X tergurid |
41/2 |
inhibitory prolaktinu, xxxxxxxxxxxx xxxxxxxx XX. xxxxxxxx, p.o. |
G02CB03 xxxxxxxxxx, X02XX04 xxxxxxxxxx |
||
42 |
Xxxxxxxxx |
42/1 |
xxxxxxxxx, p.o. |
G03CA03 xxxxxxxxx, X03XX04 xxxxxxx, X03XX05 xxxxxxx |
42/2 |
xxxxxxxxx, xxxxxxx xxx. xxxxxxxx |
X03XX03 xxxxxxxxx, X03XX04 xxxxxxx |
||
43 |
Xxxxxxxxxx |
43/1 |
xxxxxxxxxx I. xxxxxxxx, x.x. |
X03XX02 xxxxxxxxxxxxxxxxxx, X03XX02 norethisteron, G03DC03 xxxxxxxxxxx |
43/2 |
xxxxxxxxxx XX. generace, x.x. |
X03XX04 xxxxxxxxxxx, X03XX01 dydrogesteron |
||
43/3 |
progestiny, xxxxxx. |
X03XX03 hydroxyprogesteron, G03DA04 progesteron (xxxxxxx xxxxxx formy) |
||
44 |
Gonadotropiny |
44/1 |
gonadotropiny xxxxxxxx, xxxxxx. |
X03XX01 choriový xxxxxxxxxxxx, X03XX08 rekombinantní xxxxxxxx xxxxxxxxxxxx |
44/2 |
xxxxxxxxxxxxx xxxxxxx, parent. |
G03GA02 xxxxxxxxxxxx xxxxxx, xxxxxxxxxxxx xxxxxx xxxxxx xxxxxxx, X03XX04 xxxxxxxxxxxxx, urofolitropin xxxxxx xxxxxxx, X03XX05 folitropin alfa, G03GA06 xxxxxxxxxx xxxx, X03XX07 lutropin xxxx |
||
45 |
Xxxxxx spasmolytika |
45/1 |
močová spasmolytika, xxxxxxxxxxxxx xxxxx, x.x. x xxxxxxxxx. aplikace |
G04BD04 xxxxxxxxxx, X04XX06 propiverin, G04BD07 xxxxxxxxxx, X06XX09 xxxxxxxx chlorid |
45/2 |
močová spasmolytika, xxxxxxxxxxx formy, p.o. |
G04BD07 xxxxxxxxxx, X04XX08 xxxxxxxxxxx, X04XX10 xxxxxxxxxxx, X04XX11 xxxxxxxxxxx |
||
46 |
Xxxxxx x xxxxxxx xxxxxxx hyperplazie xxxxxxxx |
46/1 |
xxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxx, xxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxxxxx, x.x. |
X02XX04 doxazosin, G04CA01 alfuzosin, G04CA02 xxxxxxxxxx, X04XX03 xxxxxxxxx |
46/2 |
xxxxxx k xxxxxxx benigní xxxxxxxxxxx xxxxxxxx, xxxxxxx, x. x. |
X04XX01 xxxxxxxxxx, X04XX03 xxxxxxxxxxx |
||
47 |
Xxxxxxxxxxx xxxxxxxxx xxxxxxx |
47/1 |
xxxxxxxxxxx růstového hormonu, xxxxxxxxxx xxxxxxxx, xxxxxx. |
X01XX01 xxxxxxxxxxxx, X01XX02 xxxxxxxxx |
47/2 |
xxxxxxxxxxx xxxxxxxxx xxxxxxx - xxxxxxxxxx xxxxxxxx, xxxxxx. |
X01XX02 xxxxxxxxx, X01XX03 xxxxxxxxx |
||
48 |
Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxx xxxxxxx |
48/1 |
xxxxxxxxxxx gonadotropin - xxxxxxxxxxxx hormonu, parent. |
H01CC01 xxxxxxxxx, X010002 cetrorelix |
49 |
Kortikosteroidy k xxxxxxxxx xxxxxxx |
49/1 |
xxxxxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxxxxxxxx účinkem, x.x. |
X02XX04 methylprednisolon, H02AB07 xxxxxxxxx, X02XX08 xxxxxxxxxxxxx |
49/2 |
xxxxxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxxxxxxxx účinkem, xxxxxx. - depotní |
H02AB01 xxxxxxxxxxxx (xxxxxxx xxxxxx formy), H02AB04 xxxxxxxxxxxxxxxxx (xxxxxxx xxxxxx xxxxx) |
||
50 |
Xxxxxxxxxxxxxxx xxxxxx |
50/1 |
xxxxxxxxxxxxxxx xxxxxx, x.x. |
X03XX02 propylthiouracil, H03BB01 xxxxxxxxxx, X03XX02 xxxxxxxxxx |
51 |
Xxxxxxxxxxxx |
51 /1 |
tetracykliny, x.x. |
X01XX02 xxxxxxxxxx, X01XX08 xxxxxxxxxx |
52 |
Xxxxxxxxxx s xxxxx spektrem xxxxxx |
52/1 |
xxxxxxxxxx x xxxxx spektrem, x.x. |
X01XX02 xxxxxxxxxxxxxxxxxxxxx, X01XX06 penamecilin, J01CE10 xxxxxxxxx xxxxxxxxxxxxxxxxxxxxx |
53 |
Xxxxxxxxxxxxx |
53/1 |
xxxxxxxxxxxxx X. xxxxxxxx, x.x. |
X01XX01 cefalexin, J01DB05 xxxxxxxxxx, X01XX04 cefaklor, |
53/2 |
cefalosporiny XX. xxxxxxxx, x.x. |
X01XX02 xxxxxxxxx xxxxxx, X01XX10 cefprozil |
||
53/3 |
cefalosporiny X. xxxxxxxx, xxxxxx. |
X01XX03 xxxxxxxxx, X01XX04 xxxxxxxxx |
||
53/4 |
xxxxxxxxxxxxx XXX. xxxxxxxx, xxxxxx. (xxxxx xxxxxxxxxxxx) |
X01XX01 xxxxxxxxx, X01XX02 ceftazidim, J01DD04 ceflriaxon |
||
54 |
Karbapenemy |
54/1 |
karbapenemy, xxxxxx. |
X01XX02 xxxxxxxxx, X01XX03 ertapenem |
55 |
Makrolidová, xxxxxxxxx, ketolidová x xxxxxxxxxxxxx xxxxxxxxxxx |
55/1 |
xxxxxxxxx, p.o. |
J01FA01 xxxxxxxxxxxx, X01XX02 spiramycin, J01FA06 roxithromycin, J01FA09 xxxxxxxxxxxxxx, X01XX10 xxxxxxxxxxxx |
55/2 |
xxxxxxxxxxx, x.x. |
X01XX01 xxxxxxxxxxx, X01XX02 xxxxxxxxxx |
||
56 |
Xxxxxxxxx |
56/1 |
xxxxxxxxx, x.x. (xxxxx xxxxxxxxxxxxx) |
X01XX01 ofloxacin, J01MA02 xxxxxxxxxxxxx, X01XX03 pefloxacin, J01MA06 xxxxxxxxxxx, X01XX12 xxxxxxxxxxxx |
57 |
Xxxxxxxxxxx xxxxxxxx |
57/1 |
xxxxxxxxxxx xxxxxxxx, x.x. |
X01XX01 xxxxxxxxxxxx, X01XX03 xxxxxxxx |
58 |
Xxxxxxxxxxxx x xxxxxxxxx terapii |
58/1 |
antimykotika x systémové terapii, xxxxxxxxxx xxxxxxxx, p.o. |
J02AC03 xxxxxxxxxxx, X02XX04 xxxxxxxxxxx |
59 |
Xxxxxxxxx antivirotika xxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxx hominis |
59/1 |
systémová xxxxxxxxxxxx x terapii infekcí xxxxxxxxxx herpes virus xxxxxxx, x.x. |
X05XX01 xxxxxxxxx, X05XX09 xxxxxxxxxxx, X05XX11 xxxxxxxxxxxx, X05XX15 xxxxxxxx |
60 |
Xxxxxxxxxxxxxxxxx |
60/1 |
xxxxxxxxxxxxxxxxx xxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxx reverzní xxxxxxxxxxxx, xxxxx pro XXX xxxxxxx, x.x. |
X05XX02 didanosin, J05AF04 xxxxxxxx, X05XX06 xxxxxxxx, X05XX09 xxxxxxxxxxxx |
60/2 |
xxxxxxxxxxxxxxxxx xxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx trankriptázy, xxxxx xxx HBV xxxxxxx, x.x. |
X05XX08 xxxxxxxx, X05XX10 xxxxxxxxx |
||
61 |
Xxxxxxxxxx xxxxxxxxxxxxxx |
61/1 |
xxxxxxxxxx neuraminidázy, x. o. x xxxxx. aplikace |
J05AH01 zanamivir, J05AH02 xxxxxxxxxxx |
62 |
Xxxxxxxxxxxxxx xxxxxxxx lidské |
62/1 |
Imunoglobuliny xxxxxxxx xxxxxx, x.x. |
X06XX01 xxxxxxxxxxxxxx normální xxxxxx xxx xxxxxxxxxxxxxxx xxxxxxxx |
62/2 |
xxxxxxxxxxxxxx xxxxxxxx lidské, x.x. |
X06XX01 xxxxxxxxxxxxxx xxxxxxxx lidské xxx xxxxxxxxxx aplikaci |
||
62/3 |
Imunoglobuliny xxxxxxxx lidské, xx. |
X06XX02 xxxxxxxxxxxxxx xxxxxxxx xxxxxx xxx xxxxxxxxxxxx aplikaci |
||
63 |
Taxany |
63/1 |
taxany, xxxxxx. |
X01XX01 paklitaxel, L01CD02 xxxxxxxxx |
64 |
Xxxxxxxxxx xxxxxxxxxxxxx |
64/1 |
xxxxxxxxxx proteinkinázy, p.o. |
L01XE04 xxxxxxxxx, X01XX05 sorafenib |
65 |
Superaktivní xxxxxxx xxxxxxxxxxxx-xxxxxxxxx xxxxxxx |
65/1 |
xxxxxxxxxxxx xxxxxxx xxxxxxxxxxxx-xxxxxxxxx xxxxxxx, xxxxxx. |
X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxx, X02XX04 xxxxxxxxxxx |
66 |
Xxxxxxxxxxxxx x xxxxxxxxxx xxxxxxxx |
66/1 |
xxxxxxxxxxxxx, x.x. |
X02XX01 xxxxxxxxx, X02XX02 xxxxxxxxx |
66/2 |
xxxxxxxxxx xxxxxxxx, x.x. |
X02XX03 xxxxxxxxxx, X02XX04 xxxxxxxx, X02XX06 exemestan |
||
67 |
Antiandrogeny |
67/1 |
antiandrogeny, x.x. |
X02XX01 xxxxxxxx, X02XX03 xxxxxxxxxxx |
69 |
Xxxxxxxxxxx a xxxx xxxxxx |
69/1 |
xxxxxxxxxxx alfa xxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, - xxxxxxxxxxxx xxxxx, xxxxxx. |
X03XX01 xxxxxxxxxx alfa xxxxxxx, X03XX04 xxxxxxxxxx alfa-2a, L03AB05 xxxxxxxxxx xxxx-2x |
69/2 |
xxxxxxxxxxx xxxx-2 - pegylované formy, xxxxxx. |
X03XX11 xxxxxxxxxxxxx alfa-2a, L03AB10 xxxxxxxxxxxxx alfa-2b |
||
69/3 |
interferony x xxxxxxx léčiva k xxxxxxx xxxxxxxxxxx sklerózy, xxxxxx. |
X03XX07 xxxxxxxxxx xxxx-1x, X03XX08 xxxxxxxxxx xxxx-1x, X03XX13 glatiramer xxxxxx, |
||
70 |
Xxxxxxxxxxxxxx |
70/1 |
xxxxxxxxxxxxxx - xxxxxxxxxx, x.x. x parent. (xxxxx leflunomidu x xxxxxxxxxxxx) |
X04XX02 takrolimus, L04AA06 xxxxxxxx xxxxxxxxxxxxx, X04XX10 xxxxxxxxx, X04XX18 everolimus |
70/2 |
imunosupresiva - xxxxxxxxxx, léčiva x terapii xxxxxxxxxxxx, xxxxxxx xxxx střevních xxxxxxxxxx, xxxxxx. |
X04XX01 xxxxxxxxxx, X04XX02 xxxxxxxxxx, X04XX04 xxxxxxxxxx, X04XX21 efaliziunab, L04AA24 xxxxxxxxx |
||
71 |
Xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx |
71/1 |
xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx - xxxxxxxxxxxx, x.x. |
X01XX05 xxxxxxxxxx, X01XX01 xxxxxxxxx, X01XX05 lornoxikam, M01AC06 meloxikam, M01AE01 xxxxxxxxx, X01XX02 naproxen, M01AE03 xxxxxxxxxx, X01XX11 xxxxxxxx tiaprofenová, M01AE12 xxxxxxxxx, X01XX17 xxxxxxxxxxxxx, X01XX02 xxxxxxxx xxxxxxxxxxx, X01XX01 xxxxxxxxx, X01XX17 xxxxxxxxx |
71/2 |
xxxxxxxxxxx xxxxxxxxxxxxxx, xxxx. xxxxxxxx |
X01XX01 indometacin, M01AB05 xxxxxxxxxx, X01XX06 meloxikam, M01AE01 xxxxxxxxx, X01XX03 xxxxxxxxxx |
||
71/3 |
xxxxxxxxxxx xxxxxxxxxxxxxx, xxxxxx. |
X01XX05 xxxxxxxxxx, X01XX01 xxxxxxxxx, X01XX06 meloxikam, M01AE03 xxxxxxxxxx, X01XX04 parekoxib |
||
71/4 |
nesteroidní xxxxxxxxxxxxxx xxxxxx COX 2 xxxxxxxxxx (koxiby), x.x. |
X01XX01 xxxxxxxxx, X01XX03 valdekoxib, M01AH05 etorikoxib |
||
73 |
Centrálně xxxxxxxx xxxxxxxxxxxxx |
73/1 |
xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx, x.x. |
X03XX01 xxxxxxxx, X03XX02 xxxxxxxxx, X03XX04 tolperison, M03BX05 thiokolchikosid, M03BX07 xxxxxxxxxx, X05XX01 mefenoxalon |
73/2 |
centrálně působící xxxxxxxxxxxxx, xxxxxx. |
X03XX04 xxxxxxxxxx, X03XX05 xxxxxxxxxxxxxxx |
||
74 |
Xxxxxx x terapii x profylaxi osteoporózy |
74/1 |
léčiva x xxxxxxx x xxxxxxxxx xxxxxxxxxxx, xxxxxxx X, x.x. |
X11XX01 xxxxxxxxxxxxxx, X11XX05 xxxxxxxxxxxxxxx |
74/2 |
xxxxxx x xxxxxxx x xxxxxxxxx xxxxxxxxxxx, xxxxxxxxxx vitaminu X, x.x. |
X11XX03 xxxxxxxxxxxx, X11XX04 kalcitriol |
||
74/3 |
léčiva x terapii x xxxxxxxxx osteoporózy, xxxxxxxxxxxx, x. x. |
X05XX04 xxxxxxxx xxxxxxxxxxx, X05XX061xxxxxxxx xxxxxxxxxxx, X05XX07 kyselina xxxxxxxxxxx, |
||
74/4 |
xxxxxx x terapii x xxxxxxxxx osteoporózy, xxxxxxx xxxxxxxxxxx xxxxxxx x xxxxxxx, parent. |
H05AA02 xxxxxxxxxxx, X05XX03 parathonnon |
||
75 |
Léčiva x xxxxxxx xxxxxxxxxxxxx x/xxxx xxxxxxxxx x xxxxxxxxx xxxxxxxxxx |
75/1 |
xxxxxx x terapii xxxxxxxxxxxxx x/xxxx osteolýzy x xxxxxxxxx xxxxxxxxxx, parent. |
M05BA02 xxxxxxxx xxxxxxxxxx, X05XX03 xxxxxxxx xxxxxxxxxxx, X05XX06 xxxxxxxx xxxxxxxxxxx, X05XX08 xxxxxxxx xxxxxxxxxxx |
76 |
Xxxxxxxxxx celková |
76/1 |
anestetika celková, xxxxxx. |
X01XX01 xxxxxxxx, X01XX02 xxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX06 xxxxxxxxxxxx |
77 |
Xxxxxxxxxx lokální |
77/1 |
anestetika xxxxxxx, xxxxxx. |
X01XX02 xxxxxxx, X01XX01 xxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX09 xxxxxxxxxx, X01XX10 xxxxxxxxxxxxxx, X01XX trirnekain |
78 |
Opioidy |
78/1 |
silné opioidy, x.x. |
X02XX03 hydromorfon, N02AA05 oxykodon |
78/2 |
silné xxxxxxx, transdenn. xxxxxxxx |
X02XX03 xxxxxxxx, X02XX01 buprenorfin |
||
78/3 |
slabé xxxxxxx, x.x. |
X02XX08 xxxxxxxxxxxxx, X02XX02 xxxxxxxx |
||
79 |
Xxxxxxxxxx-xxxxxxxxxxxx |
79/1 |
xxxxxxxxxx-xxxxxxxxxxxx, x.x. |
X02XX01 kyselina xxxxxxxxxxxxxxxx, X02XX02 xxxxxxxxx, X02XX02 metarnizol, N02BE01 paracetarnol |
79/2 |
analgetika-antipyretika, xxxxxx. |
X02XX02 xxxxxxxxx X02XX01 xxxxxxxxxxxx |
||
80 |
Xxxxxxxxxxxxx x terapii xxxxxxxx xxxxxxxx |
80/1 |
xxxxxxxxxxxxx x xxxxxxx xxxxxxxx xxxxxxxx, xxxxxxxxxx xxxxxxxx serotoninu, p.o. |
N02CC01 xxxxxxxxxxx, X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxxxxx, X02XX06 xxxxxxxxxx, X02XX07 xxxxxxxxxxxx |
80/2 |
xxxxxxxxxxxxx x xxxxxxx xxxxxxxx záchvatu, xxxxxxxxxx xxxxxxxx xxxxxxxxxx, xxxxx. xxxxxxxx |
X02XX01 xxxxxxxxxxx, X02XX03 xxxxxxxxxxxx |
||
81 |
Xxxxxxxxxxxxxx xxxx |
81/1 |
xxxxxxxxxxxxxx jiná, x.x. |
X03XX12 xxxxxxxxxx, X03XX16 xxxxxxxxxx |
82 |
Xxxxxxxxxxxxxxxx |
82/1 |
xxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxx, x.x. |
X04XX02 biperiden, N04AA04 xxxxxxxxxxx, X04XX01 xxxxxxxxxxx |
82/2 |
xxxxxxxxxxxxxxxx, xxxxxxxx xxxxxxxxx, x.x. |
X04XX04 ropinirol, N04BC05 xxxxxxxxxxx |
||
82/3 |
xxxxxxxxxxxxxxxx, xxxxxxxxxx XXXX, x.x. |
X04XX01 tolkapon, N04BX02 xxxxxxxxx |
||
82/4 |
xxxxxxxxxxxxxxxx, xxxxxxxxxx XXX, p. x. |
X04XX01 xxxxxxxxx, X04XX02 xxxxxxxxx |
||
83 |
Xxxxxxxxxxxxxx xxxxxxxxxxxx |
83/1 |
xxxxxxxxxxxxxx, neuroleptika klasická - X. xxxxx, x. o. |
N05AA01 xxxxxxxxxxxxx X05XX03 xxxxxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx |
83/2 |
xxxxxxxxxxxxxx, - xxxxxxxxxxxx klasická II. xxxxx, x.x. |
X05XX01 xxxxxxxxxxx, X05XX01 xxxxxxxxxxx |
||
83/3 |
xxxxxxxxxxxxxx, neuroleptika, xxxxxx. - nedepotní |
N05AA01 xxxxxxxxxxxxx, X05XX02 xxxxxxxxxxxxxx, X05XX01 xxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx |
||
83/4 |
xxxxxxxxxxxxxx, xxxxxxxxxxxx - I. xxxxx, parent. - xxxxxxx |
X05XX02 flufenazin, N05AF xxxxxxxxxxxx |
||
83/5 |
xxxxxxxxxxxxxx, xxxxxxxxxxxx - xX. xxxxx, xxxxxx. - xxxxxxx |
X05XX01 haloperidol, N05AF01 xxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx |
||
83/6 |
xxxxxxxxxxxxxx x xxxxxx xxxxxxxxxxxxxxxx potenciálem, x.x. |
X05XX03 xxxxxxxx, X05XX03 xxxxxxx |
||
84 |
Xxxxxxxxxxxxxx - XX. xxxxxxxx |
84/1 |
xxxxxxxxxxxxxx xxxxx xxxxx xxx xxxxxxx xxxxxxxxxxx, x.x. |
X05XX03 sertindol, N05AH04 xxxxxxxxx, X05XX05 amisulprid, N05AX11 zotepin |
84/2 |
antipsychotika xxxxx xxxxx - xxxxxxxxx, x.x. |
X05XX04 ziprasidon, N05AH03 xxxxxxxxx, X05XX12 xxxxxxxxxxx |
||
84/3 |
xxxxxxxxxxxxxx speciální, xxxxxx. - xxxxxxxxx |
X05XX04 xxxxxxxxxx, X05XX03 xxxxxxxxx |
||
85 |
Xxxxxxxxxxx |
85/1 |
xxxxxxxxxxx, xxxxxxxxxxxxxx, p.o. |
N05BA01 xxxxxxxx, X05XX02 chlordiazepoxid, N05BA03 xxxxxxxxx, X05XX04 xxxxxxxx, X05XX08 bromazepam, N05BA09 xxxxxxxx, X05XX12 xxxxxxxxxx, X05XX23 xxxxxxxxx |
86 |
Xxxxxxxxxxxxx |
86/x |
xxxxxxxxxxxxx, neselektivně xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxx, x.x. |
X06XX02 xxxxxxxxx, X06XX04 xxxxxxxxxxx, X06XX08 xxxxxxxxxx, X06XX10 xxxxxxxxxxxx, X06XX16 xxxxxxxxx, X06XX21 xxxxxxxxxx, X06XX03 xxxxxxxxx |
86/2 |
xxxxxxxxxxxxx, xxxxxxxxxx inhibitory xxxxxxxx xxxxxxxxx xxxxxxxx najeden xxxxxxxxxxxxx xxxxxx (XXXX, XXXX, XXXX); reverzibilní xxxxxxxxxx xxxxxxxxxxxxxxxx (RIMA); xxxxxxxxx xxxxxxxx xxxxxxxxxx (XXX), x. x. |
X06XX03 xxxxxxxxx, X06XX04 xxxxxxxxxx, X06XX05 xxxxxxxxx, X06XX06 xxxxxxxxx, X06XX08 xxxxxxxxxx, X06XX10 xxxxxxxxxxxx, X06XX05 xxxxxxxx, X06XX14 tianeptin |
||
86/3 |
antidepresiva, xxxxxxxxxx xxxxxxxxxx xxxxxxxx monoaminů xxxxxxxx xx xxx xxxxxxxxxxxxx xxxxxxx (XXXX, XxXXX, XXXX), x.x. |
X06XX11 xxxxxxxxxx, X06XX16 xxxxxxxxxx, X06XX17 xxxxxxxxxxx, X06XX xxxxxxxxx |
||
87 |
Xxxxxx x terapii xxxxxxx Xxxxxxxxxxxx typu |
87/1 |
léčiva x terapii Xxxxxxxxxxxx xxxxxxx, x.x. a xxxxxxxxx. aplikace |
N06DA02 xxxxxxxxx, X06XX03 xxxxxxxxxxx, X06XX04 xxxxxxxxxx, X06XX01 xxxxxxxx |
88 |
Xxxxxxxxxx |
88/1 |
xxxxxxxxxx, x.x. |
X06XX02 xxxxxxxxx, X06XX03 xxxxxxxxxx, X06XX18 xxxxxxxxxx, X06XX02 extrakty z Xxxxxx biloba |
88/2 |
nootropika, xxxxxx. |
X06XX03 xxxxxxxxx, X06XX18 vinpocetin |
||
89 |
Parasympatomimetika |
89/1 |
parasympatomimetika, x.x. (xxxxx xxxxxxxxxx) |
X07XX01 neostigmin, N07AA02 xxxxxxxxxxxxx, X07XX30 ambenonium |
90 |
Léčiva xxxxxxxxx x xxxxxxx terapii x x xxxxxxxxx xxxxxxxxx xxxxxxxxx |
90/1 |
xxxxxx xxxxxxxxx x lokální xxxxxxx x x xxxxxxxxx xxxxxxxxx xxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxx. xxxxxxxx |
X01XX01 xxxxxxxxxxxx, X01XX05 xxxxxxxxx, X01XX06 xxxxxxxxx, X01XX08 flutikason |
90/2 |
léčiva xxxxxxxxx k xxxxxxx xxxxxxx x x xxxxxxxxx xxxxxxxxx xxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxx. xxxxxxxx |
X01XX02 xxxxxxxxxxxx, X01XX03 azelastin |
||
91 |
Léčiva xxxxxxxxx x xxxxxxx terapii xxxxxxx |
91/1 |
xxxxxx Xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxx, p.o. |
R03CC02 xxxxxxxxxx, X03XX08 xxxxxxxxxx, X03XX13 klenbuterol |
91/2 |
léčiva Léčiva xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxx, inhal. xxxxxxxx |
X03XX02 xxxxxxxxxx, X03XX03 xxxxxxxxxx, X03XX04 xxxxxxxxx a xxxx xxxxxxxxxxxxx |
||
92 |
Xxxxxxxxxxx antiastmatika - xxxxxxxxxxxxxxx |
92/1 |
xxxxxxxxxxx xxxxxxxxxxxxx, kortikosteroidy, - xx xxxxx xxxxxxxx, xxxxxxxx x xxxxxxx, xxxxx. aplikace |
R03BA02 xxxxxxxxx, X03XX05 flutikason, R03BA08 ciklesonid |
92/2 |
preventivní xxxxxxxxxxxxx, kortikosteroidy - xxxxxx, xxxxx xxxxxxxx |
X03XX02 xxxxxxxxx, X03XX05 xxxxxxxxxx |
||
93 |
Xxxxxxxxxxx xxxxxxxxxxxxx |
93/1 |
xxxxxxxxxxx xxxxxxxxxxxxx xx skupiny xxxxxxxxxx působících betamimetika, xxxxx. aplikace |
R03AC12 salmeterol, R03AC13 xxxxxxxxxx |
93/2 |
xxxxxxxxxxx xxxxxxxxxxxxx, xxxxxxx, x.x. |
X03XX04 xxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X03XX05 xxxxxxxxxx (xxxxxxxxxxx xxxxxx formy) |
||
93/3 |
preventivní xxxxxxxxxxxxx, antilerdcotrieny, p. x. |
X03XX01 xxxxxxxxxxx, X03XX03 xxxxxxxxxxx |
||
93/4 |
xxxxxxxxxxx xxxxxxxxxxxxx, xxxxxxxxxxxxxxxx x xxxxxxxxxxxx, xxxxx. xxxxxxxx |
X03XX01 xxxxxx xxxxxxxxxx, X03XX04 xxxxxx xxxxxxxxx |
||
93/5 |
xxxxxxxxxxx antiastmatika, xxxxx xxxxxxxxx, xxxxx. aplikace |
R03AC12 xxxxxxxxxx/ X03XX05 xxxxxxxxxx, X03XX13 formoterol/ R03BA02 xxxxxxxxx, X03XX13 xxxxxxxxxx/ X03XX01 beclomethason |
||
94 |
Expektorancia |
94/1 |
expektorancia, x.x. |
X05XX01 xxxxxxxxxxxxx, X05XX02 xxxxxxxxx, X05XX06 xxxxxxxx, X05XX15 xxxxxxxxx |
94/2 |
xxxxxxxxxxxxx, parent. x inhal. aplikace |
R05CB01 xxxxxxxxxxxxx, X05XX02 bromhexin, R05CB03 xxxxxxxxxxxx, X05XX05 xxxxx, X05XX06 ambroxol |
||
95 |
Antitusika |
95/1 |
antitusika, x. x. (xxxxx xxxxxxx) |
X05XX01 xxxxxxxxxxx, X05XX09 xxxxxxxxxxxxxxx, X05XX13 xxxxxxxxx, X05XX19 xxxxxxxxxxx, X05XX27 xxxxxxxxxxxxxxx |
96 |
Xxxxxxxxxxxxxxx |
96/1 |
xxxxxxxxxxxxxxx xxxxxxxxx, x.x. |
X06XX04 xxxxxxxxx, X06XX03 xxxxxxxxxx, X06XX02 xxxxxxxxxxx, X06XX xxxxxxxxx, X06XX02 xxxxxxxxxxxxx, X06XX17 xxxxxxxxx |
96/2 |
xxxxxxxxxxxxxxx xxxxxxxxxxx, p.o. |
R06AE07 xxxxxxxxx, X06XX09 xxxxxxxxxxxxx, X06XX13 xxxxxxxxx, X06XX27 xxxxxxxxxxxx |
||
97 |
Xxxxxxxxxxxxx - xxxxxxxxxxxxx |
97/1 |
xxxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, lok. |
S01AX11 xxxxxxxxx, X01XX13 xxxxxxxxxxxxx, X01XX17 xxxxxxxxxxxx, X01XX19 xxxxxxxxxxxx |
97/2 |
xxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx xxxxxxx, lok. |
S01AA01 xxxxxxxxxxxxxx, X01XX11 xxxxxxxxxx, X01XX12 tobramycin, S01AA13 acidiun xxxxxxxxx, X01XX24 xxxxxxxxx, X01XX04 sulfacetamid |
||
97/3 |
oftalmologika, xxxxxxxxxxxxx, xxxxxxxxxxx, lok. |
S01AD03 xxxxxxxxx, X01XX09 ganciklovir |
||
98 |
Oftahmologika - xxxxxxxxxxxxxxx |
98/1 |
xxxxxxxxxxxxx, xxxxxxxxxxxxxxx prvé xxxx, xxx. |
X01XX01 xxxxxxxxxxxx, X01XX02 xxxxxxxxxxxxx |
98/2 |
xxxxxxxxxxxxx, xxxxxxxxxxxxxxx xxxxx xxxx, xxx. |
X01XX03 xxxxxxxx, X01XX04 xxxxxxxxxxx, X01XX07 xxxxxxxxxxxxxx |
||
99 |
Xxxxxxxxxxxxx - xxxxxxxxxxxxxx xxxxxx |
99/1 |
xxxxxxxxxxxxx, xxxxxxxxxxxxxx xxxxxx, xxx. |
X01XX01 xxxxxxxxxxx, X01XX03 xxxxxxxxxx |
100 |
Xxxxxxxxxxxxx používaná x xxxxxxx glaukomu |
100/1 |
oftalmologika používaná x terapii xxxxxxxx, xxxxxxxxxxxxxxx nebo xxxxxxxxxxxxxxxxxxx, xxx. |
X01XX04 xxxxxxxx, X01XX05 brimonidin, S01EB01 xxxxxxxxxx |
100/2 |
xxxxxxxxxxxxx xxxxxxxxx k xxxxxxx glaukomu, inhibitory xxxxxxxxxxxxxx, lok. |
S01EC03 xxxxxxxxxx, X01XX04 xxxxxxxxxxx |
||
100/3 |
xxxxxxxxxxxxx používaná k xxxxxxx xxxxxxxx, xxxxxxxxxxxxx, xxx. |
X01XX01 xxxxxxx, X01XX02 xxxxxxxxx, X01XX03 xxxxxxxxxxx, X01XX05 xxxxxxxxx |
||
100/4 |
xxxxxxxxxxxxx xxxxxxxxx x terapii xxxxxxxx, xxxxxxxxxxxxxx nebo xxxxxx xxxxxxxx, xxx. |
X01XX01 xxxxxxxxxxx, X01XX02 xxxxxxxxxx, X01XX03 xxxxxxxxxxx, X01XX04 xxxxxxxxxx |
||
101 |
Xxxxxxxxxxxxx - xxxxxxxxxx x xxxxxxxxxxxx |
101/1 |
xxxxxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxxxx, lok. |
S01FA01 atropin, S01FA04 xxxxxxxxxxxxx, X01XX06 tropikamid, S01FB01 xxxxxxxxxx (xxxxxxxxxxx 10 % xxxx více) |
102 |
Oftalmologika - xxxxxxxxxxxx (xxxxx xxxxxxxxxxxxxxx) |
102/1 |
xxxxxxxxxxxxx, xxxxxxxxxxxx - antihistaminika, xxx. |
X01XX52 xxxxxxxxxx xxxxxxxxxx, X01XX02 xxxxxxxxxxxx, X01XX06 xxxxxxxxx, X01XX07 xxxxxxxxx, X01XX10 xxxxxxxxx |
102/2 |
xxxxxxxxxxxxx, xxxxxxxxxxxx - xxxxxxxxxxxxx žírných xxxxx, xxx. |
X01XX01 xxxxxxxx xxxxxxxxxxxx, X01XX03 xxxxxxxx xxxxxxxxxx, X01XX05 xxxxxxxxx, X01XX08 xxxxxxxxx, X01XX09 xxxxxxxxxx |
||
103 |
Xxxxxx xxxxxxxxx x xxxxxxx xxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx |
103/1 |
xxxxxx x xxxxxxx xxxxx xxxxxxxxx xxxxxxxxx degenerace, xxx. |
X01XX01 verteporfin, S01LA03 pegaptanib, S01LA04 xxxxxxxxxxx |
104 |
Xxxxxxxxxxxx xxxxxxxx xxxxxxxx |
104/1 |
xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx |
X01XX xxxxxxxx xxxxxxxx |
104/2 |
xxxxxxxxxxxx extrakty xxxxxxxx - xxxxxxxxxxxxxxx xxxxxxxxxx, xxxxxxxxx |
X01XX xxxxxxxx xxxxxxxx |
||
104/3 |
xxxxxxxxxxxx xxxxxxxx alergenů - standardizované xxxxxxxxxx, xxxxxxxxxxxx |
X01XX xxxxxxxx xxxxxxxx |
||
104/4 |
xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxxxx, xxxxxxxx vodné |
V01AA xxxxxxxx alergenů |
||
104/5 |
terapeutické xxxxxxxx xxxxxxxx - nestandardizované, xxxxxxxx xxxxxxx |
X01XX xxxxxxxx xxxxxxxx |
||
104/6 |
xxxxxxxxxxxx xxxxxxxx xxxxxxxx - standardizované xxxxxxxx xxxxx |
X01XX xxxxxxxx xxxxxxxx |
||
104/7 |
xxxxxxxxxxxx xxxxxxxx alergenů - xxxxxxxxxxxxxxx, injekční xxxxxxx |
X01XX xxxxxxxx xxxxxxxx |
||
105 |
Xxxxx pro xxxxxxxxx choroby |
105/1 |
testy xxx xxxxxxxxx choroby - xxxxxxxxxxxxx |
X04XX xxxxx xxx xxxxxxxxx choroby |
105/2 |
testy xxx xxxxxxxxx choroby - xxxxx xxxxx |
X04XX xxxxx xxx xxxxxxxxx xxxxxxx |
||
106 |
Xxxxxx xxxxxxxxx k xxxxxxx xxxxxxxxxxxx x xxxxxxxxxxxxxxx |
106/1 |
xxxxxx x terapii xxxxxxxxxxxx x xxxxxxxxxxxxxxx, x.x. |
X03XX02 xxxxxxxxx, X03XX03 xxxxxxxxxxxxxxx |
107 |
Xxxxxx xxx xxxxxxx xxxxxxx metabolismu |
107/1 |
definované xxxxx aminokyselin xxx xxxxxxxxxxxx (xxxxxxxx xxxxx xx obsah aminokyselin) |
V06CA01 |
107/2 |
definované xxxxx xxxxxxxxxxxx bez xxxxxxxxxxxx x obsahem xxxxxxxxx x xxxx xxx xxxx xx 1 xxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) |
X06XX02 |
||
107/3 |
xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxx pro xxxxxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) |
X06XX04 |
||
107/4 |
xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxx (xxxxxxxxx xxxxx xx obsah xxxxxxxxxxxx) |
X06XX05 |
||
107/5 |
xxxxxxxxxx xxxxx aminokyselin xxx xxxxxxxxxxxx (xxxxxxxxx xxxxx xxxxxx xx xxxxx xxxxxxxxxxxx) |
X06XX11 |
||
107/6 |
xxxxxxxxxx směsi xxxxxxxxxxxx xxxxxxxxxxxx xxx děti xx 1 xxxx x xxxxxxxx metabolismu xxxxx xxxxxxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) |
X06XX12 |
||
107/7 |
xxxxxxxxxx směsi xxxxxxxxxxxx xxxxxxxxxxxx pro xxxxxxxx xxx 1 rok x poruchou xxxxxxxxxxx xxxxx močoviny (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) |
X06XX13 |
||
107/8 |
xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxx x xxxxxx xx xxxxxxxxx x xxxx xxx xxxx xx 1 xxxx - xxxxxxxxx kojenecká xxxxxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) |
V06DD14 |
||
107/9 |
definované směsi xxxxxxxxxxxx xxx isoleucinu, xxxxxxx a xxxxxx xxx xxxx xx 1 roku (xxxxxxxx xxxxx na obsah xxxxxxxxxxxx) |
X06XX14 |
||
107/10 |
xxxxxxxxxx směsi xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxx x xxxxxx xxx xxxxxxxx nad 1 xxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) |
V06DD15 |
||
107/11 |
definované xxxxx xxxxxxxxxxxx bez xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx x xxxxxx xxx xxxx s xxxxxxxxxxxxxx x propionovou acidémií xx 1 roku (xxxxxxxx xxxxx xx xxxxx aminokyselin) |
V06DD16 |
||
107/12 |
definované xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx x xxxxxx xxx xxxxxxxx x xxxxxxxxxxxxxx x xxxxxxxxxxx acidémií xxx 1 rok (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) |
X06XX17 |
||
107/13 |
xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxx xxx xxxx do 1 xxxx (práškové formy xx obsah aminokyselin) |
V06DD18 |
||
107/14 |
definované xxxxx xxxxxxxxxxxx xxx xxxxxxx xxx xxxxxxxx xxx 1 xxx (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) |
X06XX19 |
||
107/15 |
xxxxxxxxxx xxxxx xxxxxxxxxxxx bez lysinu x xx sníženým xxxxxxxxx xxxxxxxxxx xxx xxxx s xxxxxxxxxx xxxxxxxx xx 1 xxxx (xxxxxxxx formy xx obsah aminokyselin) |
V06DD20 |
||
107/16 |
definované xxxxx xxxxxxxxxxxx xxx xxxxxx x xx xxxxxxxx xxxxxxxxx xxxxxxxxxx xxx pacienty x xxxxxxxxxx xxxxxxxx nad 1 xxx (xxxxxxxx xxxxx xx obsah xxxxxxxxxxxx) |
X06XX21 |
||
107/17 |
xxxxxxxxxx směsi xxxxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxx X-xxxxxxxx xxx xxxx x homocystinurií xx 1 roku (xxxxxxxx xxxxx xx obsah xxxxxxxxxxxx) |
X06XX22 |
||
107/18 |
xxxxxxxxxx směsi aminokyselin xxx xxxxxxxxxx obohacené X-xxxxxxxx xxx pacienty x homocystinurií xxx 1 rok (práškové xxxxx xx xxxxx xxxxxxxxxxxx) |
X06XX23 |
||
107/19 |
xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxx x xxxxxxxxxxxx se sacharidy x xxxx xxx xxxx xx 1 xxxx - xxxxxxxxx xxxxxxxxx xxxxxx (práškové xxxxx na obsah xxxxxxxxxxxx) |
X06XX26 |
||
107/20 |
xxxxxxxxxx směsi aminokyselin xxx xxxxxxxx a xxxxxxxxxxxx xxx xxxx xx 1 roku (xxxxxxxx xxxxx xx xxxxx aminokyselin) |
V06DD26 |
||
107/21 |
definované směsi xxxxxxxxxxxx xxx tyrosinu x xxxxxxxxxxxx xxx xxxxxxxx xxx 1 xxx (práškové xxxxx xx obsah xxxxxxxxxxxx) |
X06XX27 |
||
107/22 |
xxxxxxxxxx xxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxx x xxxxxxx x nízkým obsahem xxxxxxxxxxxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) |
V06DD29 |
||
108 |
Výživy xxxxxxxxx xxxxxx |
108/1 |
Xxxxxxxxx výživa xxxxxxxxxx - v xxxxxx xxxxx |
X06XX01 |
108/2 |
Xxxxxxxxx xxxxxx xxxxxxxxxx - hyperkalorická |
V06EB01 |
||
108/3 |
Polymerní xxxxxx standardní - x doplňkem xxxxxxxx xxxxxxxxxxxx |
X06XX02, X06XX04 |
||
108/4 |
Xxxxxxxxx výživa standardní - x doplňkem xxxxxxxx xxxxxxxxxxxxxxx |
X06XX02, X06XX04 |
||
108/5 |
Xxxxxxxxx výživa xxxxxxxxx - xxxxxxxxxxxxxx xxx tuku |
V06EB03 |
||
108/6 |
Polymerní xxxxxx xxxxxxxxx - xxxxxxxxxxxxxx x doplňkem xxxxxxxx xxxxx xxxxxxxx x xxxxxxxx |
X06XX05, X06XX06 |
||
108/7 |
Xxxxxxxxx xxxxxx speciální - xxxxxx pro xxxxx jaterního xxxxxxx |
X06XX10 |
||
108/8 |
Xxxxxxxxx xxxxxx speciální - x xxxxxxxx xxxxxxxx, xxxxxxxx x xxxxx |
X06XX11 |
||
108/9 |
Xxxxxxxxx xxxxxx xxxxxxxxx - x xxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxxxxx |
X06XX07, X06XX12, X06XX13, X06XX14, X06XX15, X0XXX16 |
||
108/10 |
Xxxxxxxxx výživa xxxxxxxxx - diabetická |
V06EB08 |
||
108/11 |
Polymerní xxxxxx speciální - x xxxxxxxx XXX xxxxx |
X06XX09 |
||
108/12 |
Xxxxxxxxxxxxxxx xxxxxx xxxxxx |
X06XX01 |
||
108/13 |
Xxxxxxxxxxxx |
X06XX01 |
||
109 |
Xxxxxx - xxxxxxx xxxxx |
109/1 |
xxxxxxx xxxxx x xxxxxxx xxxxxxxxx kravského xxxxx |
X06XX01 |
109/2 |
xxxxxxx xxxxx x mléčným xxxxxxxxxxx xxxxxxxxxxxx |
X06XX02 |
||
109/3 |
xxxxxxx mléka x xxxxxx xxxxxxx xxxxxxx x xxxxxxx xxxxxxxxxxx hydrolyzátem |
V06DF04 |
||
109/4 |
speciální kojenecká xxxxxx x xxxxxxx xxxxxxxxxxxx xxxxxxxxxxxx |
X06XX |
||
110 |
XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx xxxxxxxxxx látky neionické |
110/1 |
RTG xxxxxxxxxxxxx xxxxxxxxxxxxxx nefrotropní xxx-xxxxxxxxxx látky - xxxxxxxxx - xxxxxxxxxxx xxxx 150 xx/xx, xxxxxx. |
X08XX09 iodixanol, V08AB10 xxxxxxxx |
110/2 |
XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx látky - xxxxxxxxx - xxxxxxxxxxx xxxx 200 xx/xx, xxxxxx. |
X08XX04 xxxxxxxxxx, X08XX10 iomeprol |
||
110/3 |
RTG xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - koncentrace xxxx 240 mg/ml, xxxxxx. |
X08XX02 xxxxxxx, X08XX05 iopromid, V08AB07 xxxxxxxx |
||
110/4 |
XXX xxxxxxxxxxxxx nízkoosmolární xxxxxxxxxxx xxx-xxxxxxxxxx látky - xxxxxxxxx - xxxxxxxxxxx xxxx 300 xx/xx, xxxxxx. |
X08XX02 xxxxxxx, X08XX04 xxxxxxxxxx, X08XX05 xxxxxxxx, X08XX07 xxxxxxxx, X08XX10 xxxxxxxx, X08XX11 xxxxxxxxxx |
||
110/5 |
XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - neionické - xxxxxxxxxxx xxxx 320 mg/ml, parent. |
V08AB03 xxxxxxxx xxxxxxxxxxx, X08XX07 xxxxxxxx, X08XX09 xxxxxxxxx |
||
110/6 |
XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx látky - neionické - xxxxxxxxxxx xxxx 350 xx/xx, xxxxxx. |
X08XX02 xxxxxxx, X08XX07 xxxxxxxx, X08XX10 xxxxxxxx, X08XX11 xxxxxxxxxx |
||
110/7 |
XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx nefrotropní xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 370 xx/xx, xxxxxx. |
X08XX04 Xxxxxxxxx, X08XX05 xxxxxxxx |
||
111 |
Xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxx |
111/1 |
xxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxxxxx, xxxxxx. |
X08XX01 xxxxxxxxxxxx x albuminem, V08DA05 xxxxxx hexafluorid |